ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 709–720 of 2020 project topics
Pendred Syndrome SLC26A4 PDS Diagnostic Integration Platform
An integrated diagnostic platform combining SLC26A4 genetic sequencing with thyroid imaging software to identify Pendred syndrome in syndromic hearing loss patients. Captures revenue through multi-specialty bundle pricing, hospital system licenses, and endocrinology cross-referral fees.
Genetics of Hearing Loss Click to view more details →
USH2A Usher Syndrome Type 2 Precision Medicine Analytics Suite
A comprehensive digital platform that sequences USH2A variants and correlates hearing and vision phenotypes to enable early intervention and gene therapy candidate identification. Generates revenue through institutional subscriptions, pharmaceutical company partnerships for therapeutic development, and genetic counseling services.
Genetics of Hearing Loss Click to view more details →
EWAS Study Design and Batch Effect Control
Designing EWAS studies with appropriate sample sizes and developing cell type deconvolution and batch correction methods for robust methylation association testing.
Epigenome-Wide Association Studies Click to view more details →
EWAS Signal Interpretation and Causality
Distinguishing causal from confounded EWAS signals using genetic instrument approaches and studying whether methylation changes are disease drivers or passengers.
Epigenome-Wide Association Studies Click to view more details →
Longitudinal Epigenome Changes in Disease
Profiling DNA methylation changes over time in disease cohorts for identifying dynamic epigenetic changes associated with disease progression.
Epigenome-Wide Association Studies Click to view more details →
EWAS Meta-Analysis Across Cohorts
Conducting EWAS meta-analysis combining data from multiple cohorts for increasing statistical power and identifying robust methylation-disease associations.
Epigenome-Wide Association Studies Click to view more details →
Clinical Epigenetic Biomarker Discovery and Validation Platform
A SaaS platform that identifies and validates DNA methylation signatures as clinical biomarkers for disease risk stratification and patient diagnostics. Generates revenue through subscription licensing to pharmaceutical companies, diagnostic labs, and precision medicine providers seeking actionable epigenetic biomarkers.
Epigenome-Wide Association Studies Click to view more details →
High-Throughput EWAS Data Processing and Quality Control Tools
Cloud-based software suite automating methylation array preprocessing, normalization, and quality metrics for large-scale epigenome studies. Monetizes through per-sample processing fees, enterprise contracts with research institutions, and integration services for genomics laboratories.
Epigenome-Wide Association Studies Click to view more details →
Tissue-Specific Epigenetic Profiling for Personalized Medicine
A commercial diagnostic service delivering tissue-resolved epigenetic signatures to predict drug response and treatment outcomes in oncology and immunology. Generates revenue through clinical testing fees, partnership agreements with pharmaceutical companies, and licensing methylation prediction models.
Epigenome-Wide Association Studies Click to view more details →
Environmental and Lifestyle Epigenome Tracking Mobile Application
A consumer-facing app integrating EWAS data with environmental exposures and lifestyle factors to provide personalized epigenetic health insights. Monetizes through subscription tiers, corporate wellness program partnerships, and aggregated de-identified data licensing to research organizations.
Epigenome-Wide Association Studies Click to view more details →
Automated Regulatory Element Discovery from EWAS Data
An AI-powered platform that maps differentially methylated regions to regulatory elements and gene targets for drug discovery and target validation. Delivers value through licensing fees to biotech firms, contract research services, and enabling faster target-to-clinic pipelines.
Epigenome-Wide Association Studies Click to view more details →
Multi-Omics Integration Engine for Epigenome Clinical Translation
An enterprise platform integrating EWAS results with genomics, transcriptomics, and phenotype data to generate integrated molecular profiles for precision diagnostics. Enables revenue through clinical laboratory implementation, data integration consulting, and white-label licensing to healthcare systems.
Epigenome-Wide Association Studies Click to view more details →